Skip to main content
. Author manuscript; available in PMC: 2021 Apr 30.
Published in final edited form as: Curr Opin Crit Care. 2020 Feb;26(1):47–52. doi: 10.1097/MCC.0000000000000687

Table 1.

Overview of randomized controlled clinical trials comparing sedative agents

Study Year Medications Patients Results
Pohlman et al. [9] 1994 Lorazepam vs. midazolam 20 medical ICU patients Trend to faster wake up with lorazepam
Swart et al. [10] 1999 Lorazepam vs. midazolam 64 medical ICU patients Less expensive and more effective sedation with lorazepam
Kress et al. [11] 1996 Propofol vs. midazolam 73 medical ICU patients Faster wake up and equally effective sedation with propofol
Chamorro et al. [12] 1996 Propofol vs. midazolam 98 medical ICU patients Faster wake up and more effective sedation with propofol
Barrientos-Vega et al. [13] 1997 Propofol vs. midazolam 108 medical/surgical ICU patients Equally effective and more cost-effective sedation, fewer days on mechanical ventilation with propofol
Weinbroum et al. [14] 1997 Propofol vs. midazolam 67 ICU patients Equally effective sedation, midazolam more cost effective
Hall et al. [15] 2001 Propofol vs. midazolam 99 medical/surgical ICU patients Fewer days on mechanical ventilation with propofol
Carson et al. [16] 2006 Propofol vs. midazolam 132 medical ICU patients Fewer days on mechanical ventilation with propofol
Pandharipande et al. [17] 2007 Dexmedetomidine vs. lorazepam 106 medical/surgical ICU patients Less delirium and coma and more on target sedation with dexmedetomidine
Riker et al. [18] 2009 Dexmedetomidine vs. midazolam 375 medical/surgical ICU patients Less delirium and fewer days on mechanical ventilation with dexmedetomidine
Dasta et al. [19] 2010 Dexmedetomidine vs. midazolam 366 medical/surgical ICU patients Lower total ICU costs with dexmedetomidine